Drug Profile
Parathyroid hormone - Arisgen
Alternative Names: PTH - ArisgenLatest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator Arisgen
- Class Peptide hormones
- Mechanism of Action Parathyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for preclinical development in Metabolic-disorders in Switzerland (Buccal)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Metabolic-disorders in Switzerland (PO)